Investor
Finepoint Capital LP
CIK 0001608126 · filed 2026-05-14 · SEC filing
13F book
$1.95B
Positions
6
0 new · 1 sold
Largest name
13.8%
Qxo Inc
Est. mark
$20.9M
Price effect on 6 names still held. Flow −$136.6M.
| Name | Ticker | Shares | Value | Weight | Est. mark | Change |
|---|---|---|---|---|---|---|
| Qxo Inc | — | 13.9M | $269.1M | 13.8% | $1.8M | Cut−$139.4M |
| RXO, Inc. | RXO | 10.1M | $147.3M | 7.5% | $18.6M | Added$28.6M |
| Aleanna Inc | — | 490K | $396.9K | 0.0% | $327.6K | Held |
| Aleanna Inc | — | 27.7K | $229.8K | 0.0% | $150.8K | Held |
| Moneyhero Limited | — | 895K | $76.1K | 0.0% | $37.8K | Held |
| Calidi Biotherapeutics Inc | — | 1.04K | $249 | 0.0% | −$970 | Held |
Positions as of Q1 2026. 13F filings arrive up to 45 days after quarter-end and omit shorts. Values are quarter-end marks, as filed. Estimated mark is the price effect on shares still held — not realized P&L or investment advice.